Sonoma Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNOA and other ETFs, options, and stocks.About SNOA
Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants.
CEOAmy M. Trombly
CEOAmy M. Trombly
Employees168
Employees168
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded1999
Founded1999
Employees168
Employees168
SNOA Key Statistics
Market cap4.76M
Market cap4.76M
Price-Earnings ratio-1.35
Price-Earnings ratio-1.35
Dividend yield—
Dividend yield—
Average volume26.92K
Average volume26.92K
High today—
High today—
Low today—
Low today—
Open price$2.85
Open price$2.85
Volume0.00
Volume0.00
52 Week high$6.92
52 Week high$6.92
52 Week low$1.75
52 Week low$1.75
Stock Snapshot
Sonoma Pharmaceuticals(SNOA) stock is priced at $2.75, giving the company a market capitalization of 4.76M. It carries a P/E multiple of -1.35.
Sonoma Pharmaceuticals(SNOA) stock opened on 2026-02-13 at $2.85. The price climbed to — and dipped to —.
The Sonoma Pharmaceuticals(SNOA)'s current trading volume is 0, compared to an average daily volume of 26.92K.
In the last year, Sonoma Pharmaceuticals(SNOA) shares hit a 52-week high of $6.92 and a 52-week low of $1.75.
In the last year, Sonoma Pharmaceuticals(SNOA) shares hit a 52-week high of $6.92 and a 52-week low of $1.75.
People also own
Based on the portfolios of people who own SNOA. This list is generated using Robinhood data, and it’s not a recommendation.